Editorial: Drug development for neglected diseases: a public health challenge

Fehr A, Thuermann P, Razum O (2006)
TROPICAL MEDICINE & INTERNATIONAL HEALTH 11(9): 1335-1338.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Fehr, Angela; Thuermann, Petra; Razum, OliverUniBi
Einrichtung
Fakultät für Gesundheitswissenschaften > AG 3 Epidemiologie & International Public Health
Stichworte
orphan diseases; public health policy; neglected diseases
Erscheinungsjahr
2006
Zeitschriftentitel
TROPICAL MEDICINE & INTERNATIONAL HEALTH
Band
11
Ausgabe
9
Seite(n)
1335-1338
ISSN
1360-2276
eISSN
1365-3156
Page URI
https://pub.uni-bielefeld.de/record/1598089

Zitieren

Fehr A, Thuermann P, Razum O. Editorial: Drug development for neglected diseases: a public health challenge. TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2006;11(9):1335-1338.
Fehr, A., Thuermann, P., & Razum, O. (2006). Editorial: Drug development for neglected diseases: a public health challenge. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 11(9), 1335-1338. https://doi.org/10.1111/j.1365-3156.2006.01714.x
Fehr, Angela, Thuermann, Petra, and Razum, Oliver. 2006. “Editorial: Drug development for neglected diseases: a public health challenge”. TROPICAL MEDICINE & INTERNATIONAL HEALTH 11 (9): 1335-1338.
Fehr, A., Thuermann, P., and Razum, O. (2006). Editorial: Drug development for neglected diseases: a public health challenge. TROPICAL MEDICINE & INTERNATIONAL HEALTH 11, 1335-1338.
Fehr, A., Thuermann, P., & Razum, O., 2006. Editorial: Drug development for neglected diseases: a public health challenge. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 11(9), p 1335-1338.
A. Fehr, P. Thuermann, and O. Razum, “Editorial: Drug development for neglected diseases: a public health challenge”, TROPICAL MEDICINE & INTERNATIONAL HEALTH, vol. 11, 2006, pp. 1335-1338.
Fehr, A., Thuermann, P., Razum, O.: Editorial: Drug development for neglected diseases: a public health challenge. TROPICAL MEDICINE & INTERNATIONAL HEALTH. 11, 1335-1338 (2006).
Fehr, Angela, Thuermann, Petra, and Razum, Oliver. “Editorial: Drug development for neglected diseases: a public health challenge”. TROPICAL MEDICINE & INTERNATIONAL HEALTH 11.9 (2006): 1335-1338.

6 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Measuring progress in neglected disease drug development.
Cohen JP, Sturgeon G, Cohen A., Clin Ther 36(7), 2014
PMID: 24906971
The German government's global health strategy--a strategy also to support research and development for neglected diseases?
Fehr A, Razum O., Glob Health Action 7(), 2014
PMID: 25079287
Expert Delphi survey on research and development into drugs for neglected diseases.
Fehr A, Thürmann P, Razum O., BMC Health Serv Res 11(), 2011
PMID: 22087801
Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
Vicente E, Duchowicz PR, Ortiz Edel V, Monge A, Castro EA., Chem Biol Drug Des 76(1), 2010
PMID: 20492446
Development of and access to products for neglected diseases.
Cohen J, Dibner MS, Wilson A., PLoS One 5(5), 2010
PMID: 20485552
Product development partnerships (PDPs) for neglected diseases: considerations on governance.
Sorenson C., Health Econ Policy Law 4(pt 1), 2009
PMID: 19099614

25 References

Daten bereitgestellt von Europe PubMed Central.


Angell, 2004

Anonymous, The Economist Technology Quarterly (), 2005

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

Bundesministerium, 2005

CPTech, 2005
The courage to change the rules: a proposal for an essential health R&D treaty.
Dentico N, Ford N., PLoS Med. 2(2), 2005
PMID: 15736991

Depoortere, 2001

AUTHOR UNKNOWN, 2005

EMEA/COMP, 2005
Two decades of orphan product development.
Haffner ME, Whitley J, Moses M., Nat Rev Drug Discov 1(10), 2002
PMID: 12360259

Hunt, 2003

Liikanen, 2002

Moran, 2005

OrphaNet, 2006
New drugs for neglected diseases: from pipeline to patients.
Pecoul B., PLoS Med. 1(1), 2004
PMID: 15526054

Prodi, 2003
Ethics in health care priority-setting: a north-south double standard?
Stefanini A., Trop. Med. Int. Health 4(11), 1999
PMID: 10588763
Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts.
Trouiller P, Battistella C, Pinel J, Pecoul B., Trop. Med. Int. Health 4(6), 1999
PMID: 10444316
Drugs for neglected diseases: a failure of the market and a public health failure?
Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pecoul B., Trop. Med. Int. Health 6(11), 2001
PMID: 11703850

Vorholz, 2005

WHO, 2002

AUTHOR UNKNOWN, 0

World, 2006

AUTHOR UNKNOWN, 0
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 16930253
PubMed | Europe PMC

Suchen in

Google Scholar